These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9694160)

  • 21. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.
    Xie X; Guo J; Kong Y; Xie GX; Li L; Lv N; Xiao X; Tang J; Wang X; Liu P; Yang M; Xie Z; Wei W; Spencer DM; Xie X
    J Gene Med; 2011 Dec; 13(12):680-91. PubMed ID: 22009763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
    Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer.
    Hwang HC; Smythe WR; Elshami AA; Kucharczuk JC; Amin KM; Williams JP; Litzky LA; Kaiser LR; Albelda SM
    Am J Respir Cell Mol Biol; 1995 Jul; 13(1):7-16. PubMed ID: 7598939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
    J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo.
    Elshami AA; Cook JW; Amin KM; Choi H; Park JY; Coonrod L; Sun J; Molnar-Kimber K; Wilson JM; Kaiser LR; Albelda SM
    Cancer Gene Ther; 1997; 4(4):213-21. PubMed ID: 9253506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
    Sorscher EJ; Hong JS; Allan PW; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):321-9. PubMed ID: 22760227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
    Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB
    Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer.
    Singh PP; Joshi S; Russell PJ; Verma ND; Wang X; Khatri A
    Clin Cancer Res; 2011 Jun; 17(12):4006-18. PubMed ID: 21531822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
    Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer.
    Yee D; McGuire SE; Brünner N; Kozelsky TW; Allred DC; Chen SH; Woo SL
    Hum Gene Ther; 1996 Jun; 7(10):1251-7. PubMed ID: 8793549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy.
    Puhlmann M; Gnant M; Brown CK; Alexander HR; Bartlett DL
    Hum Gene Ther; 1999 Mar; 10(4):649-57. PubMed ID: 10094208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.